Moderna up 114% premarket after crushing Phase 3 melanoma trial
Their personalized mRNA cancer vaccine hit BOTH primary endpoints:
• Reduced recurrence risk
• Reduced metastasis risk
• 1,100+ patient trial
This is what mRNA was always supposed to be. Covid was just the proof of concept.
Market finally pricing in the real TAM: oncology.
The tech works. The question was always applications beyond vaccines. Now we have the answer.
Their personalized mRNA cancer vaccine hit BOTH primary endpoints:
• Reduced recurrence risk
• Reduced metastasis risk
• 1,100+ patient trial
This is what mRNA was always supposed to be. Covid was just the proof of concept.
Market finally pricing in the real TAM: oncology.
The tech works. The question was always applications beyond vaccines. Now we have the answer.